Article
Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance.
Cancer immunology research - 3 Apr 2023
Oesterreich Steffi, Aird Katherine M
Abstract excerpt
Senescent cancer cells alter their microenvironment through secretion of pro-inflammatory cytokines and chemokines called the senescence-associated secretory phenotype (SASP) and upregulation of immunoinhibitory proteins such as CD80 and programmed death-ligand 1. The senescence field is just beginning to explore the role of these changes on antitumor immunity and response to immunotherapy. In this Perspective,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
